These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6278118)

  • 1. Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics.
    Kafetzis DA; Brater DC; Kapiki AN; Papas CV; Dellagrammaticas H; Papadatos CJ
    J Pediatr; 1982 Mar; 100(3):483-9. PubMed ID: 6278118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Netilmicin: efficacy and tolerance in the treatment of systemic infections in neonates.
    Peitersen B; Hørlyk H; Nielsen M; Prag J; Korner B; Heilesen AM; Friis-Møller A
    Scand J Infect Dis Suppl; 1980; Suppl 23():151-4. PubMed ID: 6937961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of cefotaxime in pediatric patients.
    Kafetzis DA; Brater DC; Kanarios J; Sinaniotis CA; Papadatos CJ
    Antimicrob Agents Chemother; 1981 Oct; 20(4):487-90. PubMed ID: 6282194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental and clinical investigations of cefotaxime in neonates].
    Hashira S; Koike Y; Fujii R
    Jpn J Antibiot; 1982 Jul; 35(7):1737-48. PubMed ID: 6294355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical results and pharmacokinetics of cefotaxime in newborn infants].
    Takimoto M; Oka T; Yoshioka H; Sanae N; Maruyama S
    Jpn J Antibiot; 1982 Jul; 35(7):1816-8. PubMed ID: 6294362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fundamental and clinical studies of cefotaxime in neonates and immature infants].
    Nanri S; Akita H; Jozaki K; Iwata S; Iwasaki Y; Tojo M; Hotta M; Yamashita N; Sunakawa K; Oikawa T; Osano M; Ichihashi Y; Ishikawa K; Kanemitsu T; Ri S; Shirane K; Kanki K; Kawai S; Saito N
    Jpn J Antibiot; 1982 Jul; 35(7):1749-60. PubMed ID: 6294356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of bacterial infections in the newborn infant.
    Dashefsky B; Klein JO
    Clin Perinatol; 1981 Oct; 8(3):559-77. PubMed ID: 7030577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of intravenous cefotaxime therapy in neonates].
    Nakazawa S; Sato H; Hirama Y; Chikaoka H
    Jpn J Antibiot; 1982 Jul; 35(7):1761-6. PubMed ID: 6294357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.
    Martin E; Koup JR; Paravicini U; Stoeckel K
    J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of severe bacterial infections in pediatrics].
    Guggenbichler JP
    Wien Klin Wochenschr Suppl; 1983; 142():20-4. PubMed ID: 6316669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic and clinical studies on the use of cefotaxime in neonates].
    Toyonaga Y; Kurosu Y; Sugita M; Hori M
    Jpn J Antibiot; 1982 Jul; 35(7):1767-82. PubMed ID: 6294358
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of cefotaxime in newborn infants.
    McCracken GH; Threlkeld NE; Thomas ML
    Antimicrob Agents Chemother; 1982 Apr; 21(4):683-4. PubMed ID: 6282216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic study of cefotaxime in newborn infants and infants].
    Bégué P; Safran C; Sarlangue J; Quinet B; Martin C
    Arch Fr Pediatr; 1985; 42(7):547-50. PubMed ID: 4083974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of cefotaxime in gram-negative bacterial meningitis. Apropos of 3 developmental forms in neonates and infants].
    Sarlangue J; Megraud F; Nelson JR; Martin C
    Pediatrie; 1984 Dec; 39(8):645-51. PubMed ID: 6100207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.
    Henriksson P; Svenningsen NW; Juhlin I; Haeger K
    Scand J Infect Dis Suppl; 1980; Suppl 23():155-9. PubMed ID: 7010546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New concepts in the management of infants and children with meningitis.
    McCracken GH
    Pediatr Infect Dis; 1983; 2(3 Suppl):S51-5. PubMed ID: 6306611
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefotaxime pharmacokinetics and treatment of meningitis in neonates.
    Jacobs RF; Kearns GL
    Infection; 1989; 17(5):338-42. PubMed ID: 2689352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic, bacteriological and clinical studies of cefotaxime in newborn and immature infants].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Takajo N; Araki H; Imai S; Yuasa T; Tanaka Y; Tsugawa S; Nagayama K; Hashimoto T; Nakajima H; Matsuo H; Imuta F
    Jpn J Antibiot; 1982 Jul; 35(7):1819-45. PubMed ID: 6294363
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB; McCracken GH; Threlkeld N; Thomas ML
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and pharmacokinetics of cefotaxime in the treatment of neonates.
    de Louvois J; Mulhall A; Hurley R
    Pediatr Pharmacol (New York); 1982; 2(4):275-84. PubMed ID: 6099886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.